Im Cannabis Ownership

IMCC Stock  USD 2.81  0.04  1.44%   
Im Cannabis shows considerable amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.
 
Shares in Circulation  
First Issued
1997-06-30
Previous Quarter
2.2 M
Current Value
2.2 M
Avarage Shares Outstanding
1.6 M
Quarterly Volatility
3.4 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Some institutional investors establish a significant position in stocks such as Im Cannabis in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Im Cannabis, and when they decide to sell, the stock will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
The current year's Dividend Paid And Capex Coverage Ratio is expected to grow to -13.2. The current year's Common Stock Shares Outstanding is expected to grow to about 2.2 M, whereas Net Loss is forecasted to decline to (16.8 M).
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Im Cannabis Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

IMCC Stock Ownership Analysis

About 47.0% of the company shares are held by company insiders. The book value of Im Cannabis was currently reported as 6.48. The company recorded a loss per share of 4.14. Im Cannabis Corp last dividend was issued on the 18th of June 2018. The entity had 1:6 split on the 12th of July 2024. IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel, Germany, and Canada. The company serves medical patients and adult-use recreational consumers. IM Cannabis is traded on NASDAQ Exchange in the United States. To learn more about Im Cannabis Corp call Oren Shuster at 972 5 44331111 or check out https://imcannabis.com.
Besides selling stocks to institutional investors, Im Cannabis also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Im Cannabis' stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Im Cannabis' strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.

Im Cannabis Quarterly Liabilities And Stockholders Equity

44.63 Million

About 47.0% of Im Cannabis Corp are currently held by insiders. Unlike Im Cannabis' institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Im Cannabis' private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Im Cannabis' insider trades

IMCC Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Im Cannabis is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Im Cannabis Corp backward and forwards among themselves. Im Cannabis' institutional investor refers to the entity that pools money to purchase Im Cannabis' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Millennium Management Llc2024-06-30
0.0
Renaissance Technologies Corp2024-09-30
0.0
Virtu Financial Llc2024-06-30
0.0
Advisor Group Holdings, Inc.2024-06-30
0.0
Advisorshares Investments, Llc2024-06-30
620.8 K
Bank Of Montreal2024-06-30
85.5 K
Bmo Capital Markets Corp.2024-06-30
85.5 K
Citadel Advisors Llc2024-06-30
65 K
Royal Bank Of Canada2024-06-30
485
Financial Network Wealth Advisors Llc2024-06-30
100.0
Group One Trading, Lp2024-06-30
16.0
Note, although Im Cannabis' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Im Cannabis Outstanding Bonds

Im Cannabis issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Im Cannabis Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most IMCC bonds can be classified according to their maturity, which is the date when Im Cannabis Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Im Cannabis Corporate Filings

20th of November 2024
Other Reports
ViewVerify
6K
14th of November 2024
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
19th of September 2024
Other Reports
ViewVerify

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Im Cannabis Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Im Cannabis' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Im Cannabis Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Im Cannabis Corp Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Im Cannabis Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Im Cannabis. If investors know IMCC will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Im Cannabis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.14)
Revenue Per Share
22.335
Quarterly Revenue Growth
0.117
Return On Assets
(0.17)
Return On Equity
(1.12)
The market value of Im Cannabis Corp is measured differently than its book value, which is the value of IMCC that is recorded on the company's balance sheet. Investors also form their own opinion of Im Cannabis' value that differs from its market value or its book value, called intrinsic value, which is Im Cannabis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Im Cannabis' market value can be influenced by many factors that don't directly affect Im Cannabis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Im Cannabis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Im Cannabis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Im Cannabis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.